The authors conducted a telephone survey of 253 radiologists in Canada's 13 English-speaking and 13 US university-affiliated radiology departments (81% yield in a 30% target population) to gather ...

The administration of iodinated contrast media (ICM) between January 2014 and November 2024 in the US resulted in anaphylaxis at a rate of 20.3 cases per 100,000 scans, 13% of which were ...

Patients who have had acute allergic-like reactions to nonionic iodinated contrast material rarely develop any serious long-term problems and can be treated safely with commonly used medications ...

WASHINGTON -- Although FDA approval has eluded the intranasal epinephrine spray ARS-1 (also known as neffy), it continued to build its case with findings of resolved allergic symptoms in children and ...

Neffy nasal spray shows comparable efficacy to IM epinephrine for type I allergic reactions, with 92.3% symptom resolution after 1 dose.

Please provide your email address to receive an email when new articles are posted on . Successful treatment of anaphylaxis symptoms with a single dose of neffy 2 mg was found in 89.2% of patients in ...

The US Food and Drug Administration approved the first nasal spray epinephrine drug for severe allergic reactions known as anaphylaxis, providing a needle-free alternative to EpiPens and similar ...

(Reuters Health) - EpiPens and other autoinjectors filled with epinephrine to treat severe allergic reactions may still be potent enough to work many months past their labeled expiration date, ...

EpiPen is a first-line, emergency treatment for severe allergic reactions. Benadryl is used for milder allergic reactions. The decision of when to use one or the other depends on the specific symptoms ...

Patients who have had acute allergic-like reactions to nonionic iodinated contrast material rarely develop any serious long-term problems and can be treated safely with commonly used medications ...